surmount-1 tirzepatide 15 mg weight loss percent SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, The results are finally in

The FDA-approved titration schedule for Zepbound begins at 2.5 mg weekly, with increases no sooner than every 4 weeks through sequential doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and up to a maximum maintenance dose of 15 mg weekly, depending on individual response and tolerability

This means use of this compound is limited to in-vitro laboratory testing and experimentation under controlled research conditions

Patients should be counseled on proper genital hygiene practices, such as wiping from front to back and urinating after sexual activity to minimize bacterial exposure

Teenagers, particularly those on the younger side (approximately 13 to 14 years old), may have difficulty fully understanding the long-term implications of initiating a prescription